{
    "text": "Given the potent clinical activity of TRK inhibitors, we advocate that all NSCLCs be screened for NTRK fusions using a multiplexed NGS-based fusion assay.", 
    "denotations": [
        {
            "id": "T1", 
            "obj": "NSCLC", 
            "span": {
                "begin": 75, 
                "end": 80
            }
        }, 
        {
            "id": "T1", 
            "obj": "NTRK", 
            "span": {
                "begin": 98, 
                "end": 102
            }
        }
    ],
    "relations": [
        {
            "id":"R1",
            "pred":"causes",
            "subj":"T2", 
          "obj":"T1"}
    ]
}